Multi-omics (AI) Biomarker & Predictive Model Co-Development for Precision Medicine

Nexyra Advanced Research builds AI-powered multi-omics and multimodal intelligence to turn molecular and clinical data into actionable insights for diagnostics, patient stratification, and biomedical R&D decision-making.

Systems biology applied to multi-omics captures complex mechanisms beyond single-marker approaches and addresses biological heterogeneity that often limits clinical translation and R&D success. We integrate multi-layer omics (e.g., genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome) with clinical variables to develop robust signatures and predictive models tailored to specific cohorts/populations.

What we propose (Project cooperation)
A collaboration with hospitals, clinical groups, biotechs, or pharma to:

• Discover and validate biomarkers (diagnostic / stratification / monitoring).

• Build predictive and prognostic models integrating multi-omics + clinical data (AI).

• Prioritize therapeutic targets and support translational R&D decisions.

Preferred use cases (examples)

• Oncology (e.g., tumor microenvironment and immunometabolism; meta-analysis of public cohorts).

• Complex diseases with high biological heterogeneity (stratification and treatment response).

• Longevity and precision health (biological age, pathway regulation, personalized interventions).

Typical deliverables

• Reproducible pipeline (QC, harmonization, multi-omics integration, statistical analysis, ML).

• Prioritized biomarker/target list with evidence, functional interpretation, and actionable recommendations.

• Scientific report and, optionally, stakeholder-ready visualizations/dashboards.

What we need from the partner

• Access to cohorts and/or samples (retrospective or prospective) plus minimum clinical metadata.

• A “clinical champion” to define endpoints and support biological/clinical validation.

• Interest in co-publication, co-development, licensing, or progression into validation/clinical study phases.

Collaboration model

• NDA + collaboration agreement (roles, governance, milestones, IP/background IP).

• Options: (i) fee-for-service + milestone bonuses, (ii) co-development with shared IP, (iii) consortium / competitive grants.